2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3 Daclatasvir, Sofosbuvir, Ribavirin - Hepatitis C | Phase 2 | Withdrawn | Bristol-Myers Squibb | 2015-12-01 | 2016-01-15 | |
| A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1) Daclatasvir, Sofosbuvir - Hepatitis C | Phase 2 | Withdrawn | Bristol-Myers Squibb | 2015-12-01 | 2016-01-20 |
Hepatitis C (2)
Canada (2) · France (2)
2015 (2)